The pathologic status in several diseases is likely to be associated with an upset in immune system regulation, involving an imbalance between T helper 1 (Th1) and T helper 2 (Th2) cells. This study was undertaken to determine whether Th1 and Th2 disturbance exists in uremic patients, who are thought to have cellular and/or humoral immunodeficiencies. Twenty-eight non-diabetic patients undergoing chronic hemodialysis (HD) treatment and 12 age-matched healthy controls were enrolled in the study. Eleven of the HD patients had hepatitis C virus (HCV) infections, but did not have any other infections or malignancies. The Th cell profiles in HD patients were analyzed using inttracellular cytokine measurements. The cells were labeled with monoclonal antibody to CD4 (Immunotech), and intracellular cytokines, such as IFN-γ and IL-4, were stained using FASTIMMUNE intracellular staining kits (Becton Dickinson). Th1 cells were defined as IFN-γ(+), IL-4(-) cells in CD4
+ cells, and Th2 cells were defined as the IFN-γ(-), IL-4(+) cells in CD4
+ cells. All cells were defined on a single-cell basis using a flow cytometer. The Th1/Th2 ratios of HCV-negative patients and controls were the same while the ratio was significantly higher in HCV-positive patients as a result of a significant elevation in Th1. The Th1/Th2 ratios did not differ before and after HD treatment. The Th1/Th2 ratios were not correlated with any clinical data, such as age, HD duration, hematocrit, serum albumin level, intact PTH level, and serum β
2 microglobulin level. In conclusion, the immunological status in a resting state is not disturbed in stable HCV-negative HD patients, however, that of HCV-positive HD patients may be altered, possibly as a result of enhanced responses toward Th1.
View full abstract